Latest Pharmacodynamics Stories
DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/h9n884/pharmacokinetics) has announced the addition of the "Pharmacokinetics
Avail is conducting a randomized, multi-center study of the pharmacodynamics, pharmacokinetics, and tolerability of a new liquid form drug in adult patients with
Patients with renal impairment are at increased risk for developing drug-related adverse events, says In these patients drug dosage needs to be closely monitored and adjusted to reflect altered pharmacokinetics (PK) and pharmacodynamics (PD) parameters. Horsham, PA (PRWEB) August 16, 2011 Breakout sessions for study design and analysis as well as expert panel discussions will highlight DIAâ€™s Optimizing Dosing for the Safe and Effective Use of Drugs in Patients with Renal Impairment...
Doctors are using a revolutionary treatment to help patients tolerate medications that they have been allergic to.
BASKING RIDGE, N.J., Aug.
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that three posters containing data on GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), and one poster containing data on SB-743921, an inhibitor of kinesin spindle protein (KSP), were presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics held at the Geneva Palexpo, Geneva, Switzerland.